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The heterogeneous clinical presentations of individuals with autism spectrum disorders (ASDs) poses a significant
challenge for sample characterization and limits the interpretability and replicability of research studies. The
Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) diagnostic criteria for ASD, with its
dimensional approach, may be a useful framework to increase the homogeneity of research samples. In this review,
we summarize the revisions to the diagnostic criteria for ASD, briefly highlight the literature supporting these
changes, and illustrate how DSM-5 can improve sample characterization and provide opportunities for researchers
to identify possible subtypes within ASD.Review
Over the past several decades, researchers have
attempted to categorize the heterogeneity in autism
spectrum disorders (ASDs) [1-9]. This effort has been
largely unsuccessful because distinct, empirically defined
subgroups have yet to be reliably identified. The Diag-
nostic and Statistical Manual of Mental Disorders, 4th
edition (DSM-IV) used a multi-categorical system of
diagnosing pervasive developmental disorders (PDDs),
which included autistic disorder, Asperger’s disorder,
pervasive developmental disorder not otherwise speci-
fied, childhood disintegrative disorder, and Rett’s dis-
order, that created challenges to this effort. A number of
studies have reported limited reliability in how DSM-IV
subtypes are assigned [10,11], with similar core symptom
presentations across the categorical diagnoses [12-16]
and poor predictive ability of later outcome based on
these subtypes [17,18]. Consequently, the fifth edition of
the DSM (DSM-5) replaces the multi-categorical system
with a single diagnostic dimension: ASD.
Although concerns have been raised about the validity
and diagnostic sensitivity of the proposed DSM-5 criteria
[19], a number of studies have emerged in support of
the conceptual validity of the new criteria [20]. Huerta et
al. [21] found that over 90% of children with DSM-IV
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distribution, and reproduction in any mediumthe specificity using the new diagnostic criteria was sub-
stantially improved compared with the DSM-IV criteria.
Key changes in the DSM-5 ASD criteria
The change in DSM-5 that received the most media at-
tention is the removal of the DSM-IV clinical subtypes.
Less publicized were the content changes and the new
symptom structure in DSM-5. Over the past two de-
cades, an increase in access to large and diverse samples
has given researchers the ability to determine that, in
many cases, ASD symptoms are best represented in a
two-domain model of social-communication deficits and
restricted and repetitive interests/behaviors (RRB)
[22-25], rather than by the DSM-IV triad of symptoms
that models communication deficits separate from social
impairments. In addition, although the criteria for DSM-
IV Autistic Disorder required a delay in or complete lack
of development in expressive language, this requirement
has been eliminated in DSM-5 because research has
shown that this characteristic is neither specific nor uni-
versal to individuals with ASD [26-30].
Changes within symptom domains have also been
warranted. DSM-5 includes unusual sensory responses
in the RRB domain to reflect research showing that
these behaviors are prevalent in ASD [31-34] and are
useful in distinguishing ASD from other disorders
[35,36]. One feature of unusual communication, stereo-
typed language, has been reassigned to the RRB domain
to reflect results from factor analytic studies [25]. Other
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specificity.
Improved methods for subtyping?
The emphasis on specificity in the DSM-5 improves
researchers’ ability to identify samples of interest. In
addition, DSM-5 introduces a dimensional approach that
allows researchers to capture variability within samples
in two important ways. First, although DSM-5 requires
that symptoms from both the RRB and social-
communication domains are present, it allows individual
variation in the quality and quantity of specific RRBs
and social-communication deficits. Second, DSM-5 for-
mally recognizes many features that are not specific to
ASD by which researchers can qualify ASD diagnoses.
Some individuals with ASD have unique patterns of
social-communication deficits and RRBs, suggesting a
possible avenue by which ASD subgroups might be de-
fined. For example, results from a longitudinal study
suggested that RRB quantity at 2 years of age is inversely
related to language skills at 9 years [37]. With respect to
the quality of symptoms, there is some evidence to sug-
gest that ‘insistence on sameness’ behaviors are distinct
from other core ASD features and from symptoms of
anxiety [3]. ‘Insistence on sameness’ behaviors also seem
to be independent of autism symptom severity, age, and
intelligence quotient (IQ), suggesting that it may be a
useful qualitative characteristic by which to identify ASD
subtypes [38].
Individuals with ASD also display substantial variation
in the presentation of sensory abnormalities. The DSM-
5 criteria describe any unusual sensory response to the
environment, sensory reactivity, or unusual sensory in-
terests, within one dimension. Research has begun to ex-
plore the possibility of distinct ASD subgroups based on
specific patterns of sensory abnormalities [39,40]. Fur-
ther explorations are required in the area of sensory
abnormalities and in other dimensions of the RRB symp-
toms. Similarly, research has demonstrated the utility of
subgrouping within ASD based on specific social-
communication profiles [4]. Researchers should there-
fore consider both the quality and quantity of specific
ASD symptoms across social-communication and RRBs,
as these may provide useful constructs to define ASD
subgroups. This approach may also help to address the
broader conceptual question of whether (and which)
core ASD diagnostic symptoms lie along continuums,
and whether these symptoms are similarly continuous in
non-ASD samples.
Beyond the variability in the presentation of core
symptoms of ASD, DSM-5 recognizes that affected indi-
viduals also vary with respect to non-ASD symptoms,
such as cognitive ability, expressive language ability, on-
set patterns, and comorbid psychopathology. Thesedistinctions may provide additional means by which to
identify subtypes within ASD. Below, we highlight the
literature that illustrates how the dimensional approach
of DSM-5 can result in opportunities for researchers to
identify possible subtypes within ASD.
In terms of cognitive functioning, individuals with
ASD display a wide range of abilities, from severe intel-
lectual disability (ID) to superior intelligence. Studies
examining ASD individuals with and without ID have
found significant differences between groups in symp-
tom severity and later outcomes [41,42]. Moreover, defi-
cits in cognitive functioning may be more common in
females [43-46], in individuals with known genetic ab-
normalities [47,48] and in individuals with dysmorphic
features [49], suggesting the possible existence of sub-
groups with unique etiologies or risk factors. In addition,
cognitive profiles based on the relative discrepancy be-
tween verbal and non-verbal skills in ASD have been
identified [50,51]. However, clear ASD subtypes based
on specific cognitive deficits, with or without ID, have
yet to be clearly defined [1].
As noted above, DSM-5 does not consider language
delays to be part of the core symptoms of ASD because
level of language ability is highly variable in ASD. That
is, individuals with ASD differ in the degree to which
they master structural aspects of language (such as syn-
tax, morphology, and phonology) [52,53] ranging from
individuals who never develop spoken language to indi-
viduals with intact structural language abilities (who
speak in fluent, complex sentences), yet still have deficits
in the pragmatic use of language (Figure 1). These out-
comes have been associated with unique clinical presen-
tations; for example, individuals who are non-verbal
have more severe symptoms of ASD, ID [54], and oral-
motor difficulties [55]. Researchers have also suggested
that a subset of individuals with ASD may present with
language deficits that are similar to the impairments of
individuals with specific language impairment (SLI),
such as limited production of expressive language and
deficits in grammar and syntactical structure. However,
whether these deficits in individuals with ASD are dis-
tinct from or are on a continuum of deficits seen in SLI
without ASD requires further investigation [53].
Research exploring the utility of structural language
deficits as neurobiological markers of subgroups has
been promising. Neurobiological evidence suggests that
individuals with both ASD and language impairment
show similar patterns of structural brain abnormalities
in the core language areas of the brain (for example,
Wernicke’s and Broca’s areas) as those individuals with
SLI without ASD, whereas individuals with ASD without
language impairment do not show this pattern [56].
Along the same line, genetic variation in the gene
CNTNAP2 (contactin-associated protein-like 2) has
Figure 1 Illustration of the range of structural language impairment presentations in autism spectrum disorder.
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ther supporting the potential of a subtype of ASD with
comorbid SLI and unique underlying biological mecha-
nisms [57]. A more recent study found that siblings of
individuals with SLI and ASD traits were more likely
than the general population to have a diagnosis of ASD,
providing further evidence for possible combined genetic
loadings of ASD and SLI [58]. This line of inquiry em-
phasizes the necessity for researchers to thoroughly con-
sider the quality of language impairments in individuals
with ASD, as clinically meaningful variability may extend
beyond simple delay in language acquisition.
The recognition in DSM-5 of an individual’s onset pat-
tern as a clinical specifier and the removal of the specific
age of onset requirement should encourage researchers
to carefully document these details for each case. Indi-
viduals with ASD differ widely in the timing and type of
symptom onset. According to a recent meta-analysis of
85 studies, about 30% of individuals with ASD display
regressive onset profiles, usually occurring around 18
months of age [59]. Four specific types of regression
patterns have been suggested: regression in language
skills, regression in language and social skills, regressionFigure 2 Proposed Diagnostic and Statistical Manual of Mental Disord
considered when characterizing autism spectrum disorder (ASD) samin motor or adaptive functioning skills, or unspecified
regression [59]. However, other studies have identified
different patterns of regression [60-64] and some re-
searchers suggest that regressions should be considered
along a continuum [65]. The research is also mixed on
whether certain patterns of regression are associated
with specific outcomes. In some studies, regression-
onset patterns have been associated with lower verbal
ability, more severe social impairments [66,67], and pos-
sible higher rates of epilepsy [68,69], whereas other stud-
ies have found no differences between groups [61,70].
These mixed findings may be the result of variability in
how regression is operationalized across studies [59] and
the challenges that arise when parents confuse plateau-
ing skills with regression [71,72]. Additional research is
needed to understand whether different onset patterns
represent subgroups of individuals with unique trajector-
ies or biological underpinnings.
Individuals with ASD often, but not always, present
with features consistent with additional non-ASD disor-
ders, such as attention deficit/hyperactivity disorder
(ADHD), anxiety disorders, or mood disorders [73]. In
the case of individuals with ASD and comorbid ADHD,ers, 5th edition (DSM-5) criteria and associated features to be
ples.
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general psychopathology than found in those individuals
with ASD only [74]. Furthermore, there is evidence that
individuals with ASD and symptoms of combined sub-
type ADHD display a profile of difficulties (such as in-
creased oppositional behaviors) that is unique from
those with ASD and inattentive subtype ADHD [75]. Re-
sults from community-based twin studies provide evi-
dence of shared heritability in ASD and ADHD [76,77];
therefore, exploration into the overlapping and distinct
phenotypic presentations of individuals with comorbid
presentations (ASD with ADHD) versus presentations of
ADHD or ASD singly may be of potential importance for
understanding the biological markers of these disorders.What should researchers do?
In an effort to increase the specificity of the diagnostic
criteria, DSM-5 identifies both core diagnostic symp-
toms and non-ASD-specific characteristics that vary
within ASD populations. Taken together, these revisions
encourage researchers to take a dimensional approach
when studying the heterogeneous autism phenotype,
similar to approaches that have been used in population
samples [78]. Because of variations in samples (for ex-
ample, age or IQ), no single study will be sufficient to
accurately define ASD subgroups, but the emerging ac-
cumulation of research can begin to bolster understand-
ing in this area. However, in order to advance in this line
of inquiry, is it essential that researchers use adequate
sample characterization. In an effort to provide guidance
to researchers, Figure 2 illustrates the proposed DSM-5
criteria. In the next section, we expand on this list and
highlight the associated features that researchers should
consider when characterizing their ASD samples.ASD-specific symptoms
Qualitative and quantitative identification of ASD-
specific symptoms requires case confirmation of re-
search samples, using diagnostic measures that provide
both qualitative and quantitative data on the core defi-
cits in ASD.Cognitive and adaptive functioning
In addition to assessing whether or not a comorbid clas-
sification of ID is warranted, an individual’s abilities
within cognitive domains should also be assessed (verbal
and non-verbal abilities in samples with and without
ID). Another key consideration may be patterns of dis-
crepancy between cognitive and adaptive abilities, as
some individuals with ASD have difficulty with daily liv-
ing skills despite having adequate cognitive skills [79,80].Language skills
Language skills should be assessed and described, in-
cluding the current level of receptive and expressive lan-
guage skills and the quality of possible SLI.Pattern of onset
The onset pattern should be defined, including the pres-
ence or absence of early language or other skill regres-
sion. This includes thorough reports about specific skill
acquisition, regression, or plateau, as well as reports
about more global developmental delays.Comorbid symptoms
Identification of comorbid symptoms should include
both those symptoms that are sufficient for a comorbid
diagnosis and those symptoms that may not meet full
criteria for a diagnosis but are relevant as a descriptor of
an individual’s phenotype. In some cases, this will re-
quire that characterization of research samples rely on
skilled clinicians in combination with valid measures
that are capable of identifying comorbid psychopath-
ology in individuals with ASD.Other medical conditions
Researchers should investigate whether an individual has
other medical conditions including genetic conditions
and abnormalities (for example, Fragile X, Rett’s disorder,
Down syndrome), dysmorphology, and other general
medical conditions (for example, diabetes, celiac disease).Other behaviors of concern
Researchers should seek to identify other behaviors of
concern. DSM-5 allows for characterization of those in-
dividuals with increased behavioral problems, eating dif-
ficulties, and sleeping abnormalities.Conclusions
In sum, the dimensional approach of the DSM-5 is com-
prehensive in that it recognizes both core ASD symp-
toms and clinical features that are not specific to ASD.
This approach to sample characterization will help re-
searchers to increase the homogeneity of their research
samples, thus enhancing the interpretability and replic-
ability of their work. The ultimate goal is to identify
subgroups within ASD that will be important for under-
standing the biological mechanisms, clinical outcomes,
and treatment responses of individuals with ASD.
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